Hyperinsulinemic hypoglycemia after bariatric surgery: diagnosis and management experience from a Spanish multicenter registry
Since this condition may be reported as a primary diagnosis or as a condition associated with another disease, accurate and compliant reporting is essential for appropriate reimbursement
A notable example from 2019 highlights this timeline
On the clinical research side: CDER reviewed clinical data submissions for more than 150 marketing applications, investigated over 900 complaints related to bioresearch violations, and issued 21 official action indicated (OAI) / Form 483 findings, including instances where companies failed to submit required investigational new drug (IND) applications
Its enduring appreciation stems from its rich nutritional profile and versatile applications, continually proving its value for health, sustainability, and flavor enhancement in today's diverse markets
somerae ZNN-1 reduced the HSI